title: Innovations and challenges in renal cell carcinoma: summary statement from the Second Cambridge Conference.
abstract: Innovations and Challenges in Renal Cancer, chaired by Michael B. Atkins, was held April 28 to 29, 2006 in Cambridge, Massachusetts. The conference brought together leading experts in the fields of cancer research, medical oncology, urology, immunology, radiology, and immunotherapy, with the goal of advancing the field of renal cancer treatment by critiquing new data from ongoing clinical trials and stimulating communication among those involved in basic and clinical research. The conference proceedings published in this educational supplement to Clinical Cancer Research are intended to provide timely information and recommendations on important aspects of renal cancer genetics and biology and advances in prognostic classification and treatment.
authors.affiliation: Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA. matkins@bidmc.harvard.edu
authors.forename: Michael B
authors.initials: MB
authors.lastname: Atkins
authors.forename: Marc S
authors.initials: MS
authors.lastname: Ernstoff
authors.forename: Robert A
authors.initials: RA
authors.lastname: Figlin
authors.forename: Keith T
authors.initials: KT
authors.lastname: Flaherty
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: George
authors.forename: William G
authors.initials: WG
authors.lastname: Kaelin
authors.forename: Eugene D
authors.initials: ED
authors.lastname: Kwon
authors.forename: Towia A
authors.initials: TA
authors.lastname: Libermann
authors.forename: W Marston
authors.initials: WM
authors.lastname: Linehan
authors.forename: David F
authors.initials: DF
authors.lastname: McDermott
authors.forename: Augusto C
authors.initials: AC
authors.lastname: Ochoa
authors.forename: Allan J
authors.initials: AJ
authors.lastname: Pantuck
authors.forename: Brian I
authors.initials: BI
authors.lastname: Rini
authors.forename: Mark A
authors.initials: MA
authors.lastname: Rosen
authors.forename: Jeffrey A
authors.initials: JA
authors.lastname: Sosman
authors.forename: Vikas P
authors.initials: VP
authors.lastname: Sukhatme
authors.forename: Johannes W
authors.initials: JW
authors.lastname: Vieweg
authors.forename: Christopher G
authors.initials: CG
authors.lastname: Wood
authors.forename: Laura
authors.initials: L
authors.lastname: King
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000175:diagnosis / Q000235:genetics / Q000473:pathology* / Q000628:therapy*; D006801:Humans; D008954:Models, Biological; D009154:Mutation; D009362:Neoplasm Metastasis; D011379:Prognosis
chemical_list: D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents